VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
PTGX
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
PTGXProtagonist Therapeutics, Inc.
$140.85$9.1B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksPTGXPrice History

PTGX logoProtagonist Therapeutics, Inc. (PTGX) Stock Price History

Historical prices from 2016 to 2026

$140.85+9.35  (+7.11%)close Jul 7
Returns
1M
+43.7%
3M
+35.8%
YTD
+61.6%
1Y
+182.4%
3Y
+82.5%
5Y
+25.5%
ATH$141.08Jul 2026-0.2%
ATL$4.47Dec 2019pre-split
Avg Vol (50D)593K/ day
52-Week Range$49.38 — $141.08
LowCurrent: $140.85High

Loading 10-year price history...

PTGX Historical Performance

1 YearTotal Return
+182.4%
Price: +182.4%
3 YearsTotal Return
+508.2%
CAGR: +82.5%
Price: +508.2%
5 YearsTotal Return
+211.8%
CAGR: +25.5%
Price: +211.8%
YTD
+61.6%

PTGX Annual Returns

Year-by-year price performance · 2016–2026

Best+190.9%2020
Worst-69.1%2022
Up years8/11
2016+87.9%
2017-1.8%
2018-68.2%
2019+2.3%
2020+190.9%
2021+74.5%
2022-69.1%
2023+112.7%
2024+64.8%
2025+124.1%
2026+5.6%
2016 annual price return
+87.9%
2017 annual price return
-1.8%
2018 annual price return
-68.2%
2019 annual price return
+2.3%
2020 annual price return
+190.9%
2021 annual price return
+74.5%
2022 annual price return
-69.1%
2023 annual price return
+112.7%
2024 annual price return
+64.8%
2025 annual price return
+124.1%
2026 annual price return
+5.6%
LessMore
Alpha vs S&P 500
1Y+106.7%
3Y+43.4%
5Y+10.9%

Price returns only.

Download Historical Data

2,489 records • Includes OHLCV + Technical Indicators (MA50, MA200, RSI)

Free sign in required to download data

PTGX Stock Price Trajectory (2016–2026)

As of July 8, 2026, Protagonist Therapeutics, Inc. (PTGX) trades at $140.85, representing a +182.4% return over the past year. The stock has delivered a +211.8% total return over five years (+25.5% CAGR), reflecting significant long-term value creation.

The stock reached its all-time high of $141.08 on July 7, 2026. From this peak, PTGX has corrected -0.2%, currently trading 55% above its 200-day moving average, indicating continued institutional support.

When compared to Healthcare sector peers IMVT (+144.2% 1Y), KYMR (+172.2% 1Y), and PRTA (+53.9% 1Y), PTGX has underperformed the peer group average. Compare PTGX vs IMVT →

PTGX Historical Price Data · from 2016

Rows 1–50 of 2,489
Date Open High Low Close Volume Change %
2026-07-07132.59141.08130.69140.851.35M+7.11%
2026-07-06131.40132.78128.15131.50626K-0.17%
2026-07-02125.84131.84125.24131.73641K+5.24%
2026-07-01123.09126.04122.50125.17489K+2.11%
2026-06-30122.31124.72119.57122.58522K+0.78%
2026-06-29121.34126.59118.27121.63726K-0.21%
2026-06-26122.00123.43118.31121.880-0.61%
2026-06-25122.27126.19121.52122.631.02M+0.39%
2026-06-24119.85124.80118.81122.151.09M+2.68%
2026-06-23114.50119.85114.50118.96635K+3.42%
2026-06-22113.82116.33113.24115.031.17M+1.92%
2026-06-18112.88114.48111.28112.861.27M+1.27%
2026-06-17110.84113.47110.20111.44670K+0.72%
2026-06-16112.83113.66108.53110.64327K-1.62%
2026-06-15109.91112.77109.81112.46443K+2.44%
2026-06-12109.85111.78109.60109.78440K-0.01%
2026-06-11106.28110.82106.28109.79535K+3.80%
2026-06-10105.17111.45104.89105.77749K-0.09%
2026-06-0999.04106.4898.08105.87862K+8.00%
2026-06-0898.95101.1696.7098.03548K+0.67%
2026-06-05102.17102.5496.3897.38871K-5.26%
2026-06-0496.39103.6596.39102.79638K+7.74%
2026-06-0393.9395.6193.0095.41554K+2.34%
2026-06-0293.8497.7192.8393.23711K-1.78%
2026-06-0197.8598.3293.5094.92784K-4.66%
2026-05-29100.64102.4098.8499.56541K-0.85%
2026-05-28102.63103.7199.42100.41517K-1.76%
2026-05-27100.05102.4998.94102.21390K+2.23%
2026-05-26100.03100.7897.9399.98339K+0.80%
2026-05-22102.01102.4299.1399.19361K-2.76%
2026-05-21101.13103.4398.60102.01386K+1.12%
2026-05-20100.42101.9098.37100.88361K+2.55%
2026-05-19100.38100.3896.9298.37486K-2.35%
2026-05-18103.22104.16100.60100.74431K-1.41%
2026-05-15103.95104.39101.72102.18474K-3.19%
2026-05-14104.30105.72101.67105.55407K+1.61%
2026-05-1399.06104.2398.22103.88487K+3.93%
2026-05-12103.50103.5098.3499.95635K-3.43%
2026-05-11100.12105.3399.94103.50561K+4.17%
2026-05-0898.51100.1597.0099.36488K+0.52%
2026-05-07103.55104.6898.5398.85745K-4.92%
2026-05-0699.96105.0399.96103.97570K+4.72%
2026-05-05100.27101.2197.4599.28377K-0.35%
2026-05-0498.00101.0898.0099.63174K+1.28%
2026-05-0199.1699.4797.1798.37308K-0.61%
2026-04-3099.7599.7597.2098.97565K+0.46%
2026-04-29100.27100.3598.1198.52568K-2.66%
2026-04-2899.50102.4797.79101.21583K+2.74%
2026-04-27100.65102.1698.3198.51954K-1.49%
2026-04-24103.17104.2799.00100.00666K-2.55%
…
Consensus-Based Analysis Tools

Intrinsic Valuation

DCF models, multiple analysis, and analyst estimates.

Check Valuation

Historical Returns

10-year return with dividends reinvested.

Calculate

DCA Calculator

See how regular investing compounds over time.

Run Numbers

Peer Comparison

Compare growth, multiples, and margins vs sector.

Compare

PTGX — Frequently Asked Questions

Quick answers to the most common questions about buying PTGX stock.

How has PTGX stock performed recently?

PTGX returned +182.4% over the past year, beating its 5-year annualized CAGR of +25.5%. The stock trades above its 200-day moving average, confirming the uptrend.

What is PTGX's all-time high price?

Protagonist Therapeutics, Inc. reached $141.08 on 2026-07-07. The 52-week high is $141.08. Current 1-year return of +182.4% places the stock closer to historical peaks.

Where can I download PTGX historical price data?

This page provides PTGX daily OHLCV data with 50-day MA, 200-day MA, and RSI indicators. Data spans 2016-2026, downloadable in CSV format.

499 data points · sampled from 2,489